Results 121 to 130 of about 28,212,624 (348)

INTERNAL AUDIT QUALITY AND PERFORMANCE OF PUBLIC TERTIARY INSTITUTIONS IN OSUN STATE, NIGERIA

open access: yesMalete Journal of Accounting and Finance, 2023
Despite the presence of internal audit mechanism in most public tertiary institutions, evidence has shown that most of them have experienced audit failure in recent years with consequential effect on the effectiveness and efficiency in quality of ...
Khadijah Adeola IDOWU, IBRAHIM Jimoh
doaj  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Batchelor Institute of Indigenous Tertiary Education annual report 2000

open access: yes, 2000
Made available by the Northern Territory Library via the Publications (Legal Deposit) Act 2004 (NT)

core  

A differentiated model for tertiary education: past ideas, contemporary policy and future possibilities [PDF]

open access: yes, 2014
Using history as a policy tool, this report looks back at the binary system as well as its demise with the Dawkins reforms of the late 1980s to uncover the lessons learned.
Francesca Beddie
core  

Tertiary Education and Economic Growth in Tanzania [PDF]

open access: yesInternational Journal of Management, Accounting and Economics
The study examines how tertiary education impact economic growth in Tanzania, time series secondary data spanning from the year 1999 to 2023 were extracted from World Bank database.
Kembo Bwana   +2 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Batchelor Institute of Indigenous Tertiary Education annual report 2006

open access: yes, 2006
Made available by the Northern Territory Library via the Publications (Legal Deposit) Act 2004 (NT)

core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Batchelor Institute of Indigenous Tertiary Education annual report 2011

open access: yes, 2011
Made available by the Northern Territory Library via the Publications (Legal Deposit) Act 2004 (NT)

core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy